Navigation Links
Aethlon Medical Releases Shareholder Letter
Date:11/16/2011

olve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.  Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company’s clinical programs or provide market clearance of the company’s products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the Hemopurifier’s® ability to capture exosomes and the impact it may have on disease conditions, the ability to successfully complete the Medanta HCV study and achieve positive results, the company’s ability to raise capital when needed, the Company’s ability to complete the development of its planned products, the Company’s ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company’s proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company’s Securities and Exchange Commission filings.

<
'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
2. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
3. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
4. "A Medical Device Strategy To Inhibit HER2+ Breast Cancer Progression" Released by Aethlon Medical, Inc.
5. Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer
6. Aethlon Medical Releases Shareholder Letter
7. Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
8. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
9. Aethlon Medical Clarifies News Report
10. ABC News Reports on Aethlon Medical
11. Aethlon Medical Announces Multi-Target Exosome Assay Validation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014  Cardiva Medical, Inc. ... tranches of a $16.5 million Series 3 private equity ... GE Capital. The Company will use the proceeds of ... to expand commercial efforts for its VASCADE® Vascular Closure ... Investing in Series 3 private equity ...
(Date:8/19/2014)... , August 19, 2014 ... a clinical-stage pharmaceutical company focused on the development ... the Intellectual Property Department of Spain ... its invention, titled "Methods and Compositions for Oral ... Oramed Pharmaceuticals is a technology pioneer ...
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 /PRNewswire/ ... announced today a protocol amendment to allow for expanded dosing ... U.S. Food and Drug Administration (FDA) and that a new ... at three clinical trial sites in the United ... of US$2.9 million have been raised through warrant exercise in ...
Breaking Medicine Technology:Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Oramed Granted Patent in Spain for Oral Administration of Insulin 2Oramed Granted Patent in Spain for Oral Administration of Insulin 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7
... R.I., May 19, 2011 CVS Caremark Corporation (NYSE: ... President and Chief Executive Officer, will be making a ... Global Consumer Conference on May 25, 2011. Mr. Merlo ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) An audio webcast of ...
... 2011 Two studies published in Digestive ... for performing the standard upper endoscopy examination done on over ... of pre-cancerous cells in the esophagus by over 40 percent. ... 25 years, making it the fastest growing form of cancer ...
Cached Medicine Technology:Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 2Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 3Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 4
(Date:8/19/2014)... August 20, 2014 What gives skin an ... can soften skin, replenish and nourish it while lightly exfoliating? ... , "Client after client raves about how their skin feels ... founder of Sublime Beauty®. "The ingredients are very rich ... Simply smooth it over cleansed skin of the face ...
(Date:8/19/2014)... an outstanding company in the garment industry, has unveiled its ... to this, the company has also launched a big sale ... at low rates, up to 30 percent off. , ... bohemian outfits are available in many colours, including green, blush, ... quality clothes, reasonable prices and sincere service, the company has ...
(Date:8/19/2014)... CanadaGooseJackor.nu, a popular supplier of fashionable clothes, has unveiled its ... . All clients that place an order for these brand ... off) before the end of this month. , Customer ... CanadaGooseJackor.nu is a great platform for those who want to ... enjoy its dedicated professional service and fast delivery. , ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 LunaDress, a ... and cocktail dresses for ladies, is now providing a ... prom dresses . The company’s cheap white prom outfits ... V-neck, backless, and A-line outfits. , There are ... company’s product category, and the special offer is valid ...
(Date:8/19/2014)... August 20, 2014 Recently, UWDress.com, a professional ... latest assortment of plus size formal evening dresses . ... trendy plus size outfits. At the moment, all of them ... off. The promotion will be valid until August 27, 2014. ... and satisfaction. Its top designers believe that women of all ...
Breaking Medicine News(10 mins):Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2Health News:2014 Bohemian Dresses Now for Sale at Skmen.com 2Health News:High Quality Canada Goose Solaris Parkas For Sale At CanadaGooseJackor.nu 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2Health News:Cheap Plus Size Formal Evening Dresses Announced By UWDress.com 2
... five minutes before intercourse were able to delay their orgasm ... the April issue of BJU International . , Three ... 31 centres in the UK, Czech Republic, Hungary and Poland, ... spray, which contains 7.5mg of lidocaine and 2.5mg of prilocaine, ...
... 6 Against a background of economic uncertainty, people ... only in terms of their wealth but also their ... global healthcare practice of DDB Worldwide Communications Group Inc.The ... units of Omnicom Group Inc., compares perceptions about health ...
... in South Dakota implements Intergy EHR to enhance ... April 6 Today, Sage announced ... (BHOSC), a Rapid City, S.D., 15-doctor orthopedics ... electronic health records and Sage Intergy practice management ...
... acquisitions in California , , ... ("SFS") announced today that it has provided a $29,500,000 ... and Asset Funding Group, LLC ("AFG") to fund hospital ... consists of a revolving line of credit and term ...
... New Point-and-Click Animated Wizard Provides Hospitals With New ... EffectivelyCHICAGO, April 6 HIMSS09 Conference & Exhibition ... whose identity and access management (IAM) solutions are ... the availability of the Vergence Wizard, the company,s ...
... April 6 This week, the Partnership for Prescription ... research companies -- is celebrating its fourth anniversary of ... about programs that provide prescription medicines for free or ... PPA has helped more than 5.7 million patients nationwide. ...
Cached Medicine News:Health News:Premature ejaculation spray enables men to last 6 times longer after penetration 2Health News:Premature ejaculation spray enables men to last 6 times longer after penetration 3Health News:DDB Worldwide and M/A/R/C Research Find in Time of Economic Crisis: Health Is the New Wealth, Survey Shows Empowering Patients Is Key to Influence 2Health News:Black Hills Orthopedics & Spine Center Selects Sage Intergy EHR to Improve Clinical, Operational and Financial Efficiencies 2Health News:Black Hills Orthopedics & Spine Center Selects Sage Intergy EHR to Improve Clinical, Operational and Financial Efficiencies 3Health News:Siemens Financial Services, Inc. Provides $29.5 Million Credit Package to Avanti Health System 2Health News:Siemens Financial Services, Inc. Provides $29.5 Million Credit Package to Avanti Health System 3Health News:Siemens Financial Services, Inc. Provides $29.5 Million Credit Package to Avanti Health System 4Health News:Sentillion Releases Healthcare 'Do It Yourself' Tool for Single Sign-On and Context Management Application Interfaces 2Health News:Sentillion Releases Healthcare 'Do It Yourself' Tool for Single Sign-On and Context Management Application Interfaces 3Health News:Sentillion Releases Healthcare 'Do It Yourself' Tool for Single Sign-On and Context Management Application Interfaces 4Health News:Partnership for Prescription Assistance Celebrates Four-Year Anniversary; Helps More Than 5.7 Million Uninsured Patients Across United States 2Health News:Partnership for Prescription Assistance Celebrates Four-Year Anniversary; Helps More Than 5.7 Million Uninsured Patients Across United States 3
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: